Suzanne Hauffe

498 total citations
12 papers, 405 citations indexed

About

Suzanne Hauffe is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, Suzanne Hauffe has authored 12 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Suzanne Hauffe's work include Bone health and treatments (3 papers), Hemoglobinopathies and Related Disorders (2 papers) and Inflammatory mediators and NSAID effects (2 papers). Suzanne Hauffe is often cited by papers focused on Bone health and treatments (3 papers), Hemoglobinopathies and Related Disorders (2 papers) and Inflammatory mediators and NSAID effects (2 papers). Suzanne Hauffe collaborates with scholars based in Switzerland, Denmark and Germany. Suzanne Hauffe's co-authors include Gérard Flesch, René Lattmann, Pierre Acklin, Hanspeter Nick, Daniele Alberti, Lars Hyldstrup, J. Ford, Serge Leyvraz, U Hess and P. Burckhardt and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Journal of Chromatography A and Current Medicinal Chemistry.

In The Last Decade

Suzanne Hauffe

12 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Suzanne Hauffe Switzerland	9	159	142	137	47	47	12	405
Ulrike Pfaar Switzerland	10	201 1.3×	89 0.6×	131 1.0×	190 4.0×	67 1.4×	12	568
Esteban E. Sierra United States	12	120 0.8×	29 0.2×	80 0.6×	233 5.0×	19 0.4×	12	567
Goldman Id United States	11	139 0.9×	35 0.2×	137 1.0×	205 4.4×	11 0.2×	13	541
Jin Ju Kim South Korea	13	78 0.5×	43 0.3×	89 0.6×	126 2.7×	10 0.2×	42	400
Mya Thein United States	7	141 0.9×	109 0.8×	229 1.7×	103 2.2×	4 0.1×	13	450
Carol Astbury United Kingdom	13	70 0.4×	13 0.1×	40 0.3×	82 1.7×	25 0.5×	38	527
Joanna Drozd‐Sokołowska Poland	11	79 0.5×	60 0.4×	95 0.7×	52 1.1×	25 0.5×	74	389
Annie Chow United States	8	55 0.3×	107 0.8×	143 1.0×	190 4.0×	6 0.1×	11	390
Edward H. Reisner United States	11	88 0.6×	50 0.4×	64 0.5×	58 1.2×	14 0.3×	23	402
Yutaka Nakajima Japan	13	98 0.6×	35 0.2×	28 0.2×	117 2.5×	8 0.2×	34	437

Countries citing papers authored by Suzanne Hauffe

Since Specialization

Citations

This map shows the geographic impact of Suzanne Hauffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Hauffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Hauffe more than expected).

Fields of papers citing papers by Suzanne Hauffe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne Hauffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Hauffe. The network helps show where Suzanne Hauffe may publish in the future.

Co-authorship network of co-authors of Suzanne Hauffe

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne Hauffe. A scholar is included among the top collaborators of Suzanne Hauffe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne Hauffe. Suzanne Hauffe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Thaçi, Diamant, et al.. (2010). Percutaneous Absorption of Pimecrolimus Is Not Increased in Patients with Moderate to Severe Atopic Dermatitis when Pimecrolimus Cream 1% Is Applied under Occlusion. Dermatology. 221(4). 342–351. 6 indexed citations

Abdel‐Rahman, Susan M., et al.. (2005). Pharmacokinetics of Terbinafine in Young Children Treated for Tinea Capitis. The Pediatric Infectious Disease Journal. 24(10). 886–891. 19 indexed citations

Nick, Hanspeter, et al.. (2003). Development of Tridentate Iron Chelators: From Desferrithiocin to ICL670. Current Medicinal Chemistry. 10(12). 1065–1076. 139 indexed citations

Nick, Hanspeter, Pierre Acklin, Bernard Faller, et al.. (2002). ICL670A: Preclinical Profile. Advances in experimental medicine and biology. 509. 185–203. 59 indexed citations

King, Jonathan N., et al.. (1994). High performance liquid chromatography and pharmacokinetics of the non‐steroidal anti‐inflammatory drug oxindanac in calves. Journal of Veterinary Pharmacology and Therapeutics. 17(3). 186–192. 3 indexed citations

King, Jonathan N., et al.. (1994). Bidirectional chiral inversion of the enantiomers of the nonsteroidal antiinflammatory drug oxindanac in dogs. Chirality. 6(6). 460–466. 10 indexed citations

Hyldstrup, Lars, Gérard Flesch, & Suzanne Hauffe. (1993). Pharmacokinetic evaluation of pamidronate after oral administration: A study on dose proportionality, absolute bioavailability, and effect of repeated administration. Calcified Tissue International. 53(5). 297–300. 39 indexed citations

Flesch, Gérard, et al.. (1993). Influence of infusion rate on the pharmacokinetics of intravenous pamidronate (apd) in patients with bone metastases. 11–17. 1 indexed citations

Leyvraz, Serge, U Hess, Gérard Flesch, et al.. (1992). Pharmacokinetics of Pamidronate in Patients With Bone Metastases. JNCI Journal of the National Cancer Institute. 84(10). 788–792. 60 indexed citations

10.

Flesch, Gérard & Suzanne Hauffe. (1989). Determination of the bisphosphonate pamidronate disodium in urine by pre-column derivatization with fluorescamine, high-performance liquid chromatography and fluorescence detection. Journal of Chromatography B Biomedical Sciences and Applications. 489(2). 446–451. 52 indexed citations

11.

Hauffe, Suzanne, J.P. Dubois, & P Imhof. (1985). Human pharmacokinetics of cadralazine: A new vasodilator. European Journal of Drug Metabolism and Pharmacokinetics. 10(3). 217–223. 8 indexed citations

12.

Hauffe, Suzanne & J.P. Dubois. (1984). Determination of cadralazine in human plasma and urine by high-performance liquid chromatography. Journal of Chromatography A. 290. 223–230. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact